GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
K

Kairos Pharma KAPA · USD

N/A · US listing · 🇺🇸 United States

Compare

0.51

+3.48%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Latest on Kairos Pharma

Our reporting

We have not reported on Kairos Pharma yet.

Next results

13 Nov 2026

Due on 13 Nov 2026. Analysts expect earnings of -0.63 a share.

Past results

Reported against what analysts expected

12 Aug 202611 Aug 202613 May 202631 Mar 202614 Nov 202512 Aug 2025
Earnings per share-0.42-0.08-0.08-0.07-0.07-0.08
Forecast-0.63-0.09-0.07-0.02-0.10-0.06

Key events

  1. 1 Sept 20267-to-1 reverse split
  2. 16 Sept 2024Listed

Kairos Pharma in the news

Headlines from other publishers, linked to their own pages.

Sources and methodology

Data on this tab
Our reporting and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.